Naftidrofuryl

Naftidrofuryl
Naftidrofuryl
Systematic (IUPAC) name
2-(diethylamino)ethyl 3-(1-naphthyl)-2-(tetrahydrofuran-2-ylmethyl)propanoate
Clinical data
AHFS/Drugs.com International Drug Names
Pregnancy cat.  ?
Legal status  ?
Routes Oral
Identifiers
CAS number 31329-57-4
ATC code C04AX21
PubChem CID 4417
ChemSpider 4264 YesY
UNII 42H8PQ0NMJ YesY
Chemical data
Formula C24H33NO3 
Mol. mass 383.524 g/mol
SMILES eMolecules & PubChem
 YesY(what is this?)  (verify)

Naftidrofuryl (INN, also known as nafronyl or as the oxalate salt naftidrofuryl oxalate or nafronyl oxalate) is a drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic.[1] It may also be a 5-HT2 receptor antagonist. It is also licenced for the treatment of intermittent claudication due to peripheral arterial disease.

It is sold under the brand name Dusodril (Merck) and cerebromap for multiapex in middle east.

Historically, it has been used to treat sudden idiopathic hearing loss and acute tinnitus.[2]

Naftidrofuryl may be effective for relieving the pain of muscle cramps.[3]

References

  1. ^ Reynolds, J.E.F. (ed.) (1993). Martindale: The extra pharmacopoeia (30th edition ed.). London: Pharmaceutical Press. p. 1310. ISBN 0853693005. 
  2. ^ http://www.der-arzneimittelbrief.de/Jahrgang2004/Ausgabe12Seite89.htm
  3. ^ Katzberg HD, Khan AH, So YT (February 2010). "Assessment: Symptomatic treatment for muscle cramps (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology". Neurology 74 (8): 691–6. doi:10.1212/WNL.0b013e3181d0ccca. PMID 20177124.